Comparison of effectiveness of continuous versus intermittent phototherapy for treatment of non-hemolytic hyperbilirubinemia in late preterm and term infants- an open label randomized controlled trial - CICP

All India Institute of Medical Sciences0 个研究点目标入组 110 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Babies who were born at a gestation of >= 35 weeks and developed jaundice, with bilirubin cutoffs, requiring phototherapy within first two weeks of life, as per AAP practice parameter guidelines will be included in the study if parents are willing to give informed written consent

•The following babies will be excluded from the study.
•1.Babies with hemolytic jaundice â?? Rh, ABO, or minor group incompatibility with DCT positive or other hemolytic conditions like G6PD deficiency or peripheral smear showing hemolysis.
•2.Total serum bilirubin levels 20 mg/dl
•3.Sepsis (symptomatic screen positive/ culture positive)
•4.Babies who have received prior phototherapy
•5.Babies with hydrops fetalis or major congenital malformations.
•6.Non availability of dedicated phototheraphy unit at the time of assessment for eligibility.

发起方